SynchroPET has developed a miniaturized PET scanner (medical imaging device that measures radiotracer in the body) that retrofits existing medical imaging devices such as MRI or other traditional PET. In patients with cancer, for example, SynchroPET helps assess the proportion of the radiotracer absorbed by the cancerous tumours and the rest of the body over multiple scans. By being able to assess the change in absorption by not only the tumour, but also the rest of the body over time, radiologists are able to diagnose the size of the tumour with more precision than existing methods.